Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cerenis closes C round at €50M

This article was originally published in Scrip

Executive Summary

Cerenis Therapeutics has, as expected, has closed its series C round with an additional €10 million from IXO Private Equity, IRDI and an undisclosed private investor. The latest tranche takes the total funds raised in the round to €50 million and the total amount raised historically to €117 million. Cerenis completed a first closing of the round at €40 million in July, half of which came from new investor FSI, with the balance coming from existing investors Alta Partners, DAIWA Corporate Investment, EDF Ventures, HealthCap, OrbiMed, Sofinnova Partners and TVM Capital (scripintelligence.com 26 July 2010).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC010545

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel